Novocure Ltd (NASDAQ:NVCR)
| 109.01 Delayed Data As of Sep 29 |  +0.68 / +0.63%Today’s Change | 53.40 Today|||52-Week Range 110.98 | +29.36% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $10.8B |
Company Description
NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
Contact Information
Novocure Ltd. No. 4 The Forum St. Helier Jersey JE2 4UF |
Employees
Shareholders
| Mutual fund holders | 41.58% |
| Individual stakeholders | 36.23% |
| Other institutional | 27.87% |
Top Executives
| Asaf Danziger | Chief Executive Officer & Director |
| Mike Ambrogi | Chief Operating Officer |
| Wilco Groenhuysen | Chief Financial Officer |
| Uri Weinberg | Vice President-Clinical Development |
| Ely Benaim | Chief Medical Officer |
